✦ LIBER ✦

Phosphodiesterase Type 5 Inhibitors for High-Altitude Pulmonary Hypertension

✍ Scribed by Bo Jin, Xin-Ping Luo, Huan-Chun Ni, Dr Hai-Ming Shi

Book ID: 119930672
Publisher: Springer International Publishing AG
Year: 2010
Tongue: English
Weight: 123 KB
Volume: 30
Category: Article
ISSN: 1179-1918
DOI: 10.2165/11318360-000000000-00000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phosphodiesterase Type 5 Inhibitors for

Phosphodiesterase Type 5 Inhibitors for Pulmonary Arterial Hypertension

✍ Archer, Stephen L.; Michelakis, Evangelos D. 📂 Article 📅 2009 🏛 Massachusetts Medical Society 🌐 English ⚖ 543 KB

Phosphodiesterase type 5 inhibitors in p

Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension

✍ David Montani; Marie-Camille Chaumais; Laurent Savale; Delphine Natali; Laura C. 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 216 KB

Cochrane Database of Systematic Reviews

Cochrane Database of Systematic Reviews (Reviews) || Phosphodiesterase 5 inhibitors for pulmonary hypertension

✍ Kanthapillai, Parthipan 📂 Article 📅 2004 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 291 KB

Effect of DMPPO, a phosphodiesterase typ

Effect of DMPPO, a phosphodiesterase type 5 inhibitor, on hypoxic pulmonary hypertension in rats

✍ Saadia Eddahibi; Bernadette Raffestin; Anne-Charlotte Le Monnier de Gouville; Se 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 284 KB

Type 5 phosphodiesterase inhibition in h

Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension

✍ Gregory D. Lewis; Marc J. Semigran 📂 Article 📅 2004 🏛 Current Science Inc. 🌐 English ⚖ 332 KB

Long-term Inhaled Nitric Oxide Plus Phos

Long-term Inhaled Nitric Oxide Plus Phosphodiesterase 5 Inhibitors for Severe Pulmonary Hypertension

✍ Gregorio Miguel Pérez-Peñate; Gabriel Juliá-Serdà; Nazario Ojeda-Betancort; Anto 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 646 KB